retatrutide parkinson's disease clinical trial Retatrutide approval: FDA status, trial results, and when it could be available New Parkinson's Treatments in the
Description
Lets break down how each works
Recommendations: Maintain consistent hydration Monitor persistent GI symptoms Replenish electrolytes when clinically indicated Severe or prolonged symptoms require medical review
Administered as a once-weekly subcutaneous injection
Hydration and Electrolytes Adequate hydration supports both side effect management and overall metabolic function
